PASSPOINT PRO
NURS 5334 Comprehensive
Final
Practice Exam
200 Clinical Pharmacology Questions with Answers & Detailed Rationales | UTA
200 A-D Detailed
QUESTIONS FORMAT RATIONALES
Original clinical practice material for advanced pharmacology review with emphasis
on mechanisms, medication selection, adverse effects, contraindications,
interactions, monitoring, patient education, and safe prescribing.
COURSE INSTITUTION
NURS 5334 - Advanced Pharmacology for Nurse
Practitioners University of Texas at Arlington (UTA)
FORMAT APPROACH
Clinical application, safety, monitoring & patient
A-D multiple choice + answers + detailed rationales teaching
PRACTICE SMARTER. PREPARE BETTER.
,PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
PRACTICE EXAM
HOW TO USE THIS SET
Answer each question before reading the rationale. Focus on the safest and most pharmacologically sound
choice. Use missed questions to identify knowledge gaps.
COVERAGE
foundations | antimicrobials | cardiovascular | endocrine | respiratory | neuro/psych | ENT/GU/MSK |
pain/GI/reproductive | special populations
QUESTIONS 1-25
1
A patient with several chronic conditions presents for routine follow-up. A patient asks
how Aspirin antiplatelet therapy works. Which response by the NP is most accurate?
A. Directly inhibit a clotting factor such as factor Xa
B. Irreversibly inhibits platelet COX-1 and reduces thromboxane A2
C. Blocks L-type calcium channels in vascular smooth muscle and causes arterial vasodilation
D. Selectively blocks beta-1 adrenergic receptors at usual doses
ANSWER: B
EXPLANATION: Aspirin antiplatelet therapy irreversibly inhibits platelet COX-1 and reduces thromboxane A2. This
pharmacologic action explains why it is used for secondary prevention of atherosclerotic events in selected patients.
Key safety considerations include gastrointestinal bleeding, dyspepsia, and bronchospasm in sensitive patients, with
monitoring focused on bleeding symptoms and GI tolerance.
2
An advanced-practice nurse is reconciling medications before making a treatment
decision. During a case conference, which mechanism should be associated with
Acyclovir/valacyclovir?
A. Binds the 50S ribosomal subunit and prevents formation of the initiation complex
B. Inhibit viral DNA polymerase after activation in infected cells
C. Bind the 30S ribosomal subunit and inhibit bacterial protein synthesis
D. Bind the 50S ribosomal subunit and inhibit bacterial protein synthesis
ANSWER: B
EXPLANATION: Acyclovir/valacyclovir inhibit viral DNA polymerase after activation in infected cells. This pharmacologic
action explains why it is used for herpes simplex and varicella-zoster infections. Key safety considerations include
crystal-associated kidney injury at high exposure and neurotoxicity in renal impairment, with monitoring focused on
kidney function and hydration status.
3
An adult patient is being seen in primary care. Which patient factor should prompt the
NP to avoid or substantially reconsider Naloxone?
A. Severe active liver disease without clinician guidance
B. No absolute contraindication in life-threatening opioid toxicity
C. GI obstruction or history of tardive dyskinesia
D. Current breast cancer for many progestin methods
ANSWER: B
EXPLANATION: The most important reason to avoid or reconsider therapy is No absolute contraindication in
life-threatening opioid toxicity. In that setting, the known pharmacology of Naloxone can increase the risk of acute
withdrawal, agitation, pain recurrence, and sympathetic surge. A safer alternative or specialist-guided plan should be
considered rather than proceeding without risk mitigation.
PassPoint Pro | Practice smarter. Prepare better. Page 2 of 53
,PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
4
An advanced-practice nurse is reconciling medications before making a treatment
decision. A patient asks how Metronidazole works. Which response by the NP is most
accurate?
A. Sequentially inhibits bacterial folate synthesis
B. Inhibit bacterial cell-wall synthesis
C. Binds the 50S ribosomal subunit and prevents formation of the initiation complex
D. Forms reactive metabolites that disrupt microbial DNA
ANSWER: D
EXPLANATION: Metronidazole forms reactive metabolites that disrupt microbial DNA. This pharmacologic action
explains why it is used for anaerobic bacterial and selected protozoal infections. Key safety considerations include
metallic taste, nausea, neuropathy with prolonged use, and CNS effects, with monitoring focused on neurologic
symptoms with prolonged therapy and clinical response.
5
During a medication-management visit, the nurse practitioner reviews the regimen.
Which instruction should the NP prioritize for a patient starting Roflumilast?
A. Increasing rescue use signals poor control and should prompt reassessment
B. Rinse the mouth after use and take the controller consistently
C. Avoid spraying medication into the eyes and report urinary retention
D. Report significant weight loss or mood changes
ANSWER: D
EXPLANATION: The best teaching point is to report significant weight loss or mood changes. This instruction directly
addresses a major safety issue associated with Roflumilast, including weight loss, diarrhea, insomnia, and psychiatric
symptoms. Clear counseling improves adherence and helps the patient recognize when follow-up or urgent evaluation
is needed.
6
An adult patient is being seen in primary care. Which finding during follow-up would
make the clinician most suspicious of a known adverse effect of Steady-state dosing?
A. Accumulation and dose-related toxicity can occur as kidney function declines
B. Variable or reduced systemic exposure after oral dosing
C. Premature dose escalation can cause later accumulation and toxicity
D. Concentrations may rise or fall when metabolism is inhibited or induced
ANSWER: C
EXPLANATION: The best answer is Premature dose escalation can cause later accumulation and toxicity. Steady-state
dosing reaches an average plateau when drug input and elimination are balanced, and clinically important adverse
effects include premature dose escalation can cause later accumulation and toxicity. Appropriate follow-up includes
response after enough half-lives have elapsed, and patients should be taught to follow titration intervals rather than
adjusting based on one early dose.
7
A patient asks about a recently prescribed medication. Which patient factor should
prompt the NP to avoid or substantially reconsider Atomoxetine?
A. Concurrent or recent MAOI use
B. Pregnancy for migraine prevention and many situations where fetal risk is unacceptable
C. Significant bradycardia or conduction disease without assessment
D. Use in dementia-related psychosis carries increased mortality warning
ANSWER: A
EXPLANATION: The most important reason to avoid or reconsider therapy is Concurrent or recent MAOI use. In that
setting, the known pharmacology of Atomoxetine can increase the risk of nausea, increased heart rate/blood pressure,
and rare liver injury or suicidal thinking. A safer alternative or specialist-guided plan should be considered rather than
proceeding without risk mitigation.
PassPoint Pro | Practice smarter. Prepare better. Page 3 of 53
, PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
8
A graduate NP student is evaluating a new prescription. For which patient would
Long-acting muscarinic antagonists be least appropriate without specialist guidance
or risk mitigation?
A. Untreated severe airway infection without appropriate management
B. Moderate-to-severe hepatic impairment
C. Seizure or uncontrolled arrhythmia risk without close supervision
D. Urinary retention or narrow-angle glaucoma without risk assessment
ANSWER: D
EXPLANATION: The most important reason to avoid or reconsider therapy is Urinary retention or narrow-angle
glaucoma without risk assessment. In that setting, the known pharmacology of Long-acting muscarinic antagonists can
increase the risk of dry mouth, urinary retention, and glaucoma symptoms if exposed to eyes. A safer alternative or
specialist-guided plan should be considered rather than proceeding without risk mitigation.
9
During a medication-management visit, the nurse practitioner reviews the regimen. A
patient asks how Combined estrogen-progestin contraceptives works. Which response
by the NP is most accurate?
A. Block histamine H2 receptors on gastric parietal cells
B. Suppress ovulation through hypothalamic-pituitary feedback and alter cervical mucus/endometrium
C. Blocks dopamine D2 receptors and enhances upper GI motility
D. Reduces central prostaglandin synthesis through mechanisms not fully defined
ANSWER: B
EXPLANATION: Combined estrogen-progestin contraceptives suppress ovulation through hypothalamic-pituitary
feedback and alter cervical mucus/endometrium. This pharmacologic action explains why it is used for contraception
and selected menstrual disorders. Key safety considerations include venous thromboembolism, hypertension, nausea,
and headache, with monitoring focused on blood pressure, smoking status, and thrombotic risk.
10
An adult patient is being seen in primary care. Which statement by a patient
prescribed SGLT2 inhibitors demonstrates correct understanding of the teaching plan?
A. Hold during prolonged fasting or acute serious illness when instructed and seek care for nausea or rapid
breathing even if glucose is not very high
B. Follow fluid-restriction instructions and report headache, confusion, or sudden weight gain
C. Eat smaller meals during titration and report persistent severe abdominal pain
D. Recognize and treat hypoglycemia and rotate injection sites
ANSWER: A
EXPLANATION: The best teaching point is to hold during prolonged fasting or acute serious illness when instructed and
seek care for nausea or rapid breathing even if glucose is not very high. This instruction directly addresses a major
safety issue associated with SGLT2 inhibitors, including genital mycotic infection, volume depletion, and euglycemic
ketoacidosis. Clear counseling improves adherence and helps the patient recognize when follow-up or urgent
evaluation is needed.
11
During follow-up, the clinician performs a focused medication review. During a case
conference, which mechanism should be associated with ICS/LABA combination
therapy?
A. Inhibits phosphodiesterase and antagonizes adenosine, producing bronchodilation
B. Stimulates beta-2 adrenergic receptors and relaxes bronchial smooth muscle
C. Combines anti-inflammatory glucocorticoid action with prolonged beta-2 bronchodilation
D. Inhibits phosphodiesterase-4 and reduces inflammation
ANSWER: C
EXPLANATION: ICS/LABA combination therapy combines anti-inflammatory glucocorticoid action with prolonged beta-2
bronchodilation. This pharmacologic action explains why it is used for maintenance treatment of asthma or COPD
when indicated. Key safety considerations include oral candidiasis, tremor, tachycardia, and paradoxical
bronchospasm, with monitoring focused on control symptoms and inhaler technique.
PassPoint Pro | Practice smarter. Prepare better. Page 4 of 53
NURS 5334 Comprehensive
Final
Practice Exam
200 Clinical Pharmacology Questions with Answers & Detailed Rationales | UTA
200 A-D Detailed
QUESTIONS FORMAT RATIONALES
Original clinical practice material for advanced pharmacology review with emphasis
on mechanisms, medication selection, adverse effects, contraindications,
interactions, monitoring, patient education, and safe prescribing.
COURSE INSTITUTION
NURS 5334 - Advanced Pharmacology for Nurse
Practitioners University of Texas at Arlington (UTA)
FORMAT APPROACH
Clinical application, safety, monitoring & patient
A-D multiple choice + answers + detailed rationales teaching
PRACTICE SMARTER. PREPARE BETTER.
,PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
PRACTICE EXAM
HOW TO USE THIS SET
Answer each question before reading the rationale. Focus on the safest and most pharmacologically sound
choice. Use missed questions to identify knowledge gaps.
COVERAGE
foundations | antimicrobials | cardiovascular | endocrine | respiratory | neuro/psych | ENT/GU/MSK |
pain/GI/reproductive | special populations
QUESTIONS 1-25
1
A patient with several chronic conditions presents for routine follow-up. A patient asks
how Aspirin antiplatelet therapy works. Which response by the NP is most accurate?
A. Directly inhibit a clotting factor such as factor Xa
B. Irreversibly inhibits platelet COX-1 and reduces thromboxane A2
C. Blocks L-type calcium channels in vascular smooth muscle and causes arterial vasodilation
D. Selectively blocks beta-1 adrenergic receptors at usual doses
ANSWER: B
EXPLANATION: Aspirin antiplatelet therapy irreversibly inhibits platelet COX-1 and reduces thromboxane A2. This
pharmacologic action explains why it is used for secondary prevention of atherosclerotic events in selected patients.
Key safety considerations include gastrointestinal bleeding, dyspepsia, and bronchospasm in sensitive patients, with
monitoring focused on bleeding symptoms and GI tolerance.
2
An advanced-practice nurse is reconciling medications before making a treatment
decision. During a case conference, which mechanism should be associated with
Acyclovir/valacyclovir?
A. Binds the 50S ribosomal subunit and prevents formation of the initiation complex
B. Inhibit viral DNA polymerase after activation in infected cells
C. Bind the 30S ribosomal subunit and inhibit bacterial protein synthesis
D. Bind the 50S ribosomal subunit and inhibit bacterial protein synthesis
ANSWER: B
EXPLANATION: Acyclovir/valacyclovir inhibit viral DNA polymerase after activation in infected cells. This pharmacologic
action explains why it is used for herpes simplex and varicella-zoster infections. Key safety considerations include
crystal-associated kidney injury at high exposure and neurotoxicity in renal impairment, with monitoring focused on
kidney function and hydration status.
3
An adult patient is being seen in primary care. Which patient factor should prompt the
NP to avoid or substantially reconsider Naloxone?
A. Severe active liver disease without clinician guidance
B. No absolute contraindication in life-threatening opioid toxicity
C. GI obstruction or history of tardive dyskinesia
D. Current breast cancer for many progestin methods
ANSWER: B
EXPLANATION: The most important reason to avoid or reconsider therapy is No absolute contraindication in
life-threatening opioid toxicity. In that setting, the known pharmacology of Naloxone can increase the risk of acute
withdrawal, agitation, pain recurrence, and sympathetic surge. A safer alternative or specialist-guided plan should be
considered rather than proceeding without risk mitigation.
PassPoint Pro | Practice smarter. Prepare better. Page 2 of 53
,PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
4
An advanced-practice nurse is reconciling medications before making a treatment
decision. A patient asks how Metronidazole works. Which response by the NP is most
accurate?
A. Sequentially inhibits bacterial folate synthesis
B. Inhibit bacterial cell-wall synthesis
C. Binds the 50S ribosomal subunit and prevents formation of the initiation complex
D. Forms reactive metabolites that disrupt microbial DNA
ANSWER: D
EXPLANATION: Metronidazole forms reactive metabolites that disrupt microbial DNA. This pharmacologic action
explains why it is used for anaerobic bacterial and selected protozoal infections. Key safety considerations include
metallic taste, nausea, neuropathy with prolonged use, and CNS effects, with monitoring focused on neurologic
symptoms with prolonged therapy and clinical response.
5
During a medication-management visit, the nurse practitioner reviews the regimen.
Which instruction should the NP prioritize for a patient starting Roflumilast?
A. Increasing rescue use signals poor control and should prompt reassessment
B. Rinse the mouth after use and take the controller consistently
C. Avoid spraying medication into the eyes and report urinary retention
D. Report significant weight loss or mood changes
ANSWER: D
EXPLANATION: The best teaching point is to report significant weight loss or mood changes. This instruction directly
addresses a major safety issue associated with Roflumilast, including weight loss, diarrhea, insomnia, and psychiatric
symptoms. Clear counseling improves adherence and helps the patient recognize when follow-up or urgent evaluation
is needed.
6
An adult patient is being seen in primary care. Which finding during follow-up would
make the clinician most suspicious of a known adverse effect of Steady-state dosing?
A. Accumulation and dose-related toxicity can occur as kidney function declines
B. Variable or reduced systemic exposure after oral dosing
C. Premature dose escalation can cause later accumulation and toxicity
D. Concentrations may rise or fall when metabolism is inhibited or induced
ANSWER: C
EXPLANATION: The best answer is Premature dose escalation can cause later accumulation and toxicity. Steady-state
dosing reaches an average plateau when drug input and elimination are balanced, and clinically important adverse
effects include premature dose escalation can cause later accumulation and toxicity. Appropriate follow-up includes
response after enough half-lives have elapsed, and patients should be taught to follow titration intervals rather than
adjusting based on one early dose.
7
A patient asks about a recently prescribed medication. Which patient factor should
prompt the NP to avoid or substantially reconsider Atomoxetine?
A. Concurrent or recent MAOI use
B. Pregnancy for migraine prevention and many situations where fetal risk is unacceptable
C. Significant bradycardia or conduction disease without assessment
D. Use in dementia-related psychosis carries increased mortality warning
ANSWER: A
EXPLANATION: The most important reason to avoid or reconsider therapy is Concurrent or recent MAOI use. In that
setting, the known pharmacology of Atomoxetine can increase the risk of nausea, increased heart rate/blood pressure,
and rare liver injury or suicidal thinking. A safer alternative or specialist-guided plan should be considered rather than
proceeding without risk mitigation.
PassPoint Pro | Practice smarter. Prepare better. Page 3 of 53
, PASSPOINT PRO NURS 5334 | ADVANCED PHARMACOLOGY
8
A graduate NP student is evaluating a new prescription. For which patient would
Long-acting muscarinic antagonists be least appropriate without specialist guidance
or risk mitigation?
A. Untreated severe airway infection without appropriate management
B. Moderate-to-severe hepatic impairment
C. Seizure or uncontrolled arrhythmia risk without close supervision
D. Urinary retention or narrow-angle glaucoma without risk assessment
ANSWER: D
EXPLANATION: The most important reason to avoid or reconsider therapy is Urinary retention or narrow-angle
glaucoma without risk assessment. In that setting, the known pharmacology of Long-acting muscarinic antagonists can
increase the risk of dry mouth, urinary retention, and glaucoma symptoms if exposed to eyes. A safer alternative or
specialist-guided plan should be considered rather than proceeding without risk mitigation.
9
During a medication-management visit, the nurse practitioner reviews the regimen. A
patient asks how Combined estrogen-progestin contraceptives works. Which response
by the NP is most accurate?
A. Block histamine H2 receptors on gastric parietal cells
B. Suppress ovulation through hypothalamic-pituitary feedback and alter cervical mucus/endometrium
C. Blocks dopamine D2 receptors and enhances upper GI motility
D. Reduces central prostaglandin synthesis through mechanisms not fully defined
ANSWER: B
EXPLANATION: Combined estrogen-progestin contraceptives suppress ovulation through hypothalamic-pituitary
feedback and alter cervical mucus/endometrium. This pharmacologic action explains why it is used for contraception
and selected menstrual disorders. Key safety considerations include venous thromboembolism, hypertension, nausea,
and headache, with monitoring focused on blood pressure, smoking status, and thrombotic risk.
10
An adult patient is being seen in primary care. Which statement by a patient
prescribed SGLT2 inhibitors demonstrates correct understanding of the teaching plan?
A. Hold during prolonged fasting or acute serious illness when instructed and seek care for nausea or rapid
breathing even if glucose is not very high
B. Follow fluid-restriction instructions and report headache, confusion, or sudden weight gain
C. Eat smaller meals during titration and report persistent severe abdominal pain
D. Recognize and treat hypoglycemia and rotate injection sites
ANSWER: A
EXPLANATION: The best teaching point is to hold during prolonged fasting or acute serious illness when instructed and
seek care for nausea or rapid breathing even if glucose is not very high. This instruction directly addresses a major
safety issue associated with SGLT2 inhibitors, including genital mycotic infection, volume depletion, and euglycemic
ketoacidosis. Clear counseling improves adherence and helps the patient recognize when follow-up or urgent
evaluation is needed.
11
During follow-up, the clinician performs a focused medication review. During a case
conference, which mechanism should be associated with ICS/LABA combination
therapy?
A. Inhibits phosphodiesterase and antagonizes adenosine, producing bronchodilation
B. Stimulates beta-2 adrenergic receptors and relaxes bronchial smooth muscle
C. Combines anti-inflammatory glucocorticoid action with prolonged beta-2 bronchodilation
D. Inhibits phosphodiesterase-4 and reduces inflammation
ANSWER: C
EXPLANATION: ICS/LABA combination therapy combines anti-inflammatory glucocorticoid action with prolonged beta-2
bronchodilation. This pharmacologic action explains why it is used for maintenance treatment of asthma or COPD
when indicated. Key safety considerations include oral candidiasis, tremor, tachycardia, and paradoxical
bronchospasm, with monitoring focused on control symptoms and inhaler technique.
PassPoint Pro | Practice smarter. Prepare better. Page 4 of 53
